HSBC Holdings’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-57,200
Closed -$4.54M 3012
2026
Q1
$4.54M Hold
57,200
﹤0.01% 1198
2025
Q4
$4.9M Hold
57,200
﹤0.01% 1220
2025
Q3
$4.43M Hold
57,200
﹤0.01% 1230
2025
Q2
$4.47M Hold
57,200
﹤0.01% 1199
2025
Q1
$4.13M Buy
57,200
+41,400
+262% +$2.96M ﹤0.01% 1174
2024
Q4
$1.17M Hold
15,800
﹤0.01% 1716
2024
Q3
$1.04M Hold
15,800
﹤0.01% 1669
2024
Q2
$1.47M Buy
+15,800
New +$1.4M ﹤0.01% 1509
2021
Q2
Sell
-21,200
Closed -$1.77M 2967
2021
Q1
$1.77M Buy
21,200
+3,300
+18% +$279K ﹤0.01% 1345
2020
Q4
$1.62M Buy
17,900
+9,900
+124% +$821K ﹤0.01% 1418
2020
Q3
$645K Buy
+8,000
New +$624K ﹤0.01% 1780
2020
Q1
Sell
-107,700
Closed -$8.35M 2791
2019
Q4
$8.35M Sell
107,700
-157,200
-59% -$12.3M 0.01% 887
2019
Q3
$19.4M Buy
264,900
+225,600
+574% +$15.8M 0.04% 545
2019
Q2
$2.42M Buy
+39,300
New +$2.38M ﹤0.01% 1452
2019
Q1
Sell
-10,800
Closed -$551K 2756
2018
Q4
$551K Hold
10,800
﹤0.01% 2062
2018
Q3
$627K Hold
10,800
﹤0.01% 1931
2018
Q2
$524K Sell
10,800
-60,600
-85% -$2.83M ﹤0.01% 2049
2018
Q1
$3.32M Buy
+71,400
New +$3.1M ﹤0.01% 1256

Other funds holding EW

HSBC Holdings's EW Position: Q2 2026 in Review

HSBC Holdings reduced its Edwards Lifesciences (EW) stake by 11% in Q2 2026, selling an estimated $16.9M and leaving 1,569,398 shares worth $142M. The position accounts for 0.06% of the portfolio, ranked #296.

HSBC Holdings first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $183M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • HSBC Holdings held 1,569,398 shares of Edwards Lifesciences worth $142M as of Q2 2026.
  • HSBC Holdings sold 201,564 Edwards Lifesciences shares in Q2 2026, an estimated $16.9M.
  • Edwards Lifesciences made up 0.06% of HSBC Holdings's portfolio in Q2 2026, its #296 holding.
  • HSBC Holdings first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • HSBC Holdings's Edwards Lifesciences position peaked at $183M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.